ML
IDXX icon

McAdam LLC’s Idexx Laboratories IDXX Stock Holding History

McAdam LLC’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Buy
470
+48
+11% +$26.9K 0.01% 433
2026
Q1 		$237K Buy
422
+10
+2% +$6.41K 0.01% 384
2025
Q4 		$278K Buy
412
+36
+10% +$24.5K 0.01% 338
2025
Q3 		$240K Buy
+376
New +$228K 0.01% 353
2018
Q4 		– Sell
-82
Closed -$20K – 299
2018
Q3 		$20K Buy
82
+2
+3% +$485 0.01% 253
2018
Q2 		$17K Hold
80
– – 0.01% 264
2018
Q1 		$15K Buy
+80
New +$14.8K 0.01% 282

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

McAdam LLC's IDXX Position: Q2 2026 in Review

McAdam LLC increased its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, buying an estimated $26.9K and bringing the position to 470 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #433.

McAdam LLC first reported a position in IDXX in Q1 2018 and has held it in 7 quarters since. The position peaked at $278K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • McAdam LLC held 470 shares of Idexx Laboratories worth $247K as of Q2 2026.
  • McAdam LLC bought 48 Idexx Laboratories shares in Q2 2026, an estimated $26.9K.
  • Idexx Laboratories made up 0.01% of McAdam LLC's portfolio in Q2 2026, its #433 holding.
  • McAdam LLC first reported a position in Idexx Laboratories in Q1 2018 and has held it in 7 quarters since.
  • McAdam LLC's Idexx Laboratories position peaked at $278K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.